Platelet membrane fluidity and peroxynitrite levels in migraine patients during headache-free periods

被引:38
|
作者
Taffi, R
Vignini, A
Lanciotti, C
Luconi, R
Nanetti, L
Mazzanti, L
Provinciali, L
Silvestrini, M
Bartolini, M
机构
[1] Univ Politecn Marche, Dept Neurosci, Ancona, Italy
[2] Univ Politecn Marche, Inst Biochem, Ancona, Italy
关键词
migraine; peroxynitrite; platelet membrane;
D O I
10.1111/j.1468-2982.2004.00863.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Previous investigations have suggested that changes in platelet activity may play a key role in the pathophysiology of migraine via mechanisms involving the nitric oxide (NO) pathway. Changes in platelet response and nitrite levels have recently been demonstrated during migraine attacks, while there is considerable uncertainty about NO activity in headache-free periods. A reactive oxidant produced from NO and superoxide anion at the site of inflammation, peroxynitrite (ONOO-) has effects including changes in membrane activity and fluidity. The aim of the present study was to determine ONOO- levels in the platelets of patients suffering from migraine during the headache-free period. Nitric oxide synthase (eNOS and iNOS) expression in platelets and the effects of ONOO- on membrane Na+/K+-ATPase activity and membrane fluidity were also evaluated. Subjects were 57 patients suffering from migraine without aura and 35 controls. Blood samples were collected in the headache-free period. Platelet ONOO- levels were determined using dichlorofluorescein acetate with steady-state fluorescence. Platelets were then probed for induction of eNOS and iNOS expression by western immunoblotting. Membrane Na+/K+-ATPase activity and fluidity were determined with the fluorescent probes TMA-DPH and DPH. In the presence of extracellular L-arginine(100 mu mol/l), ONOO- production was significantly greater in patients' platelets than in those of controls (P < 0.001). Western immunoblotting of platelet proteins evidenced higher iNOS expression in patients than in controls. In addition, platelet membrane Na+/K+-ATPase activity and membrane fluidity evaluated by TMA-DPH were significantly lower in patients (P < 0.001). In conclusion, migraine patients show intercritic changes in platelet membrane fluidity and activity that may be related to the oxidative stress caused by increased ONOO- levels.
引用
收藏
页码:353 / 358
页数:6
相关论文
共 50 条
  • [21] ALPHA-RHYTHM IN CLASSICAL MIGRAINE (MIGRAINE WITH AURA) - ABNORMALITIES IN THE HEADACHE-FREE INTERVAL
    NYRKE, T
    KANGASNIEMI, P
    LANG, H
    [J]. CEPHALALGIA, 1990, 10 (04) : 177 - 181
  • [22] ALEXITHYMIA AND RIGIDITY IN HEADACHE PATIENTS, AND THE SCREENING OF HEADACHE-FREE CONTROLS
    ISLER, H
    REGARD, M
    SCHWEINBERGER, H
    [J]. HEADACHE, 1987, 27 (05): : 291 - 291
  • [23] Fremanezumab for preventive treatment of migraine Functional status on headache-free days
    VanderPluym, Juliana
    Dodick, David W.
    Lipton, Richard B.
    Ma, Yuju
    Loupe, Pippa S.
    Bigal, Marcelo E.
    [J]. NEUROLOGY, 2018, 91 (12) : E1152 - E1165
  • [24] Decreased plasma RANTES/CCL5 concentration in headache-free episodic migraine patients
    Gecse, K.
    Nagy, T.
    Kornyei, Z.
    Denes, A.
    Bagdy, G.
    Juhasz, G.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [25] Consecutive Headache-Free Days With OnabotulinumtoxinA Treatment in Patients With Chronic Migraine: A Pooled PREEMPT Analysis
    Diener, H. C.
    Dodick, D. W.
    Lipton, R. B.
    Sommer, K.
    Silberstein, S. D.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 105 - 105
  • [26] Abnormal resting-state brain activity in headache-free migraine patients: A magnetoencephalography study
    Li, Feng
    Xiang, Jing
    Wu, Ting
    Zhu, Donglin
    Shi, Jingping
    [J]. CLINICAL NEUROPHYSIOLOGY, 2016, 127 (08) : 2855 - 2861
  • [27] Consecutive headache-free days with OnabotulinumtoxinA treatment in patients with chronic migraine: A pooled PREEMPT analysis
    Diener, H. C.
    Dodick, D. W.
    Lipton, R. B.
    Sommer, K.
    Silberstein, S. D.
    [J]. HEADACHE, 2021, 61 : 117 - 117
  • [28] Consecutive Headache-Free Days With OnabotulinumtoxinA Treatment in Patients With Chronic Migraine: A Pooled PREEMPT Analysis
    Diener, H. C.
    Dodick, D. W.
    Lipton, R. B.
    Sommer, K.
    Silberstein, S. D.
    [J]. CEPHALALGIA, 2021, 41 (1_SUPPL) : 155 - 156
  • [29] Upper cervical two-point discrimination thresholds in migraine patients and headache-free controls
    Luedtke, Kerstin
    Adamczyk, Waclaw
    Mehrtens, Katrin
    Moeller, Inken
    Rosenbaum, Louisa
    Schaefer, Axel
    Schroeder, Janine
    Szikszay, Tibor
    Zimmer, Christian
    Wollesen, Bettina
    [J]. JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [30] Consecutive Headache-Free Days With OnabotulinumtoxinA Treatment in Patients With Chronic Migraine: A Pooled PREEMPT Analysis
    Diener, Hans-Christoph
    Dodick, David W.
    Lipton, Richard B.
    Sommer, Katherine
    Silberstein, Stephen D.
    [J]. NEUROLOGY, 2021, 96 (15)